Literature DB >> 11120801

Ig light chain receptor editing in anergic B cells.

L E Tze1, E A Baness, K L Hippen, T W Behrens.   

Abstract

Receptor editing in the bone marrow (BM) serves to modify the Ag receptor specificity of immature self-reactive B cells, while anergy functionally silences self-reactive clones. Here, we demonstrate that anergic B cells in hen egg lysozyme Ig (HEL-Ig)/soluble HEL double transgenic mice show evidence of having undergone receptor editing in vivo, as demonstrated by the presence of elevated levels of endogenous kappa light chain rearrangements in the BM and spleen. In an in vitro IL-7-driven BM culture system, HEL-Ig BM B cells grown in the presence of soluble HEL down-regulated surface IgM expression and also showed induction of new endogenous kappa light chain rearrangements. Using a panel of soluble protein ligands with reduced affinity for the HEL-Ig receptor, the editing response was shown to correlate in a dose-dependent fashion with the strength of signaling through the B cell receptor. The finding that the level of B cell receptor cross-linking sufficient to induce anergy in B cells is also capable of engaging the machinery required for receptor editing suggests an intimate relationship between these two mechanisms in maintaining B cell tolerance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120801     DOI: 10.4049/jimmunol.165.12.6796

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation.

Authors:  Claire L Adams; Megan K L Macleod; E James Milner-White; Robert Aitken; Paul Garside; David I Stott
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

2.  Proximal events in 7,12-dimethylbenz[a]anthracene-induced, stromal cell-dependent bone marrow B cell apoptosis: stromal cell-B cell communication and apoptosis signaling.

Authors:  Jessica E Teague; Heui-Young Ryu; Michael Kirber; David H Sherr; Jennifer J Schlezinger
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

Review 3.  The role of immune tolerance in preventing and treating arthritis.

Authors:  Gijs Teklenburg; Salvatore Albani
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

Review 4.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

5.  Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.

Authors:  Rachel H Bonami; James W Thomas
Journal:  J Immunol       Date:  2015-10-02       Impact factor: 5.422

Review 6.  Secondary receptor editing in the generation of autoimmunity.

Authors:  Robert A Eisenberg
Journal:  Autoimmun Rev       Date:  2012-02-14       Impact factor: 9.754

7.  The role of CaMKII in calcium-activated death pathways in bone marrow B cells.

Authors:  Stephanie L Bissonnette; Amelia Haas; Koren K Mann; Jennifer J Schlezinger
Journal:  Toxicol Sci       Date:  2010-09-01       Impact factor: 4.849

8.  Phospholipase Cgamma2 contributes to light-chain gene activation and receptor editing.

Authors:  Li Bai; Yuhong Chen; Yinghong He; Xuezhi Dai; Xueyan Lin; Renren Wen; Demin Wang
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

Review 9.  B-cell antigen-receptor signalling in lymphocyte development.

Authors:  Leo D Wang; Marcus R Clark
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

10.  NF-kappaB activity marks cells engaged in receptor editing.

Authors:  Emily J Cadera; Fengyi Wan; Rupesh H Amin; Hector Nolla; Michael J Lenardo; Mark S Schlissel
Journal:  J Exp Med       Date:  2009-07-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.